Study Group: Aranesp Prescribers for Red Blood Cell Disorders (US)(?)
Council Members in this Study Group: 52
Request a survey with this Study Group
Leading Experts in this Study Group
 |
What is a GLG Leader? |
Donald Fleming, MDDivision Head of Hematology and Oncology
Davis Health System, Inc.
Donald Fleming, MD, is the Head of Hematology-Oncology at the Medical Center of Vincennes. Previously, Dr. Fleming was a Tenured Professor in the Division of Hematology-Oncology at University of Louisville. He has published over 25 manuscripts in peer-reviewed journals and remains involved in clinical...
Kenneth Algazy, MDClinical Professor of Medicine
University of Pennsylvania School of Medicine - CC
Dr. Kenneth Algazy, MD, is a Clinical Professor of Medicine at University of Pennsylvania School of Medicine. He is also a Section Chief in the Division of Hematology and Oncology at Philadelphia VA Medical Center. Dr. Algazy is involved in clinical trials in lung cancer, and interested in demographics...
Assistant Professor of Medicine
University of Pennsylvania Cancer Center
Donald Tsai, MD, PhD, is an Assistant Professor of Medicine at the University of Pennsylvania Cancer Center. Dr. Tsai specializes in the treatment of hematological malignancies such as leukemia, multiple myeloma, lymphoma, Hodgkin's disease, myelodysplastic syndromes (MDS), and bone marrow transplantation....
Richard Amerling, MDDirector of Outpatient Dialysis
BETH ISRAEL MEDICAL CENTER INC
Richard Amerling, MD, is Director of Outpatient Dialysis and Continuous Renal Replacement Therapy at the Beth Israel Medical Center in New York City. Dr. Amerling has an extensive background in all aspects of consultative nephrology including hypertension, kidney stones, glomerular diseases, diabetes,...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Experts(?)
We may be able to analyze EGFR mutations from periperal blood of lung cancer patients. Very frequently enough tissue fromm needle biopsies are not available for analysis. This may replace the need for new biopsies.
This oral Vascular Endothelial Growth Factor (VEGF) inhibitor appears to have activity in radioresistant differentiated thyroid carcinoma.
Patients who wish to receive Avastin for breast and lung Cancer will need to pay for it themselves.
Rising costs for care of seniors in physician offices will be made more painful by the reimbursement cuts. Will it impede care of seniors??
Due to possible tumor growth warnings will be attached to the use of erythropoietin agents.
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Government/Military Hospital or Clinic
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Owner
- Partner
- Chief Executive Officer
- Physician - Director
- President
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms